Edition:
United States

Bruker Corp (BRKR.OQ)

BRKR.OQ on NASDAQ Stock Exchange Global Select Market

35.22USD
22 Nov 2017
Change (% chg)

-- (--)
Prev Close
$35.22
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
155,752
52-wk High
$35.41
52-wk Low
$21.04

Chart for

About

Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies... (more)

Overall

Beta: 1.08
Market Cap(Mil.): $5,478.92
Shares Outstanding(Mil.): 155.56
Dividend: 0.04
Yield (%): 0.45

Financials

  Industry Sector
P/E (TTM): -- 31.43 15.54
EPS (TTM): -- -- --
ROI: -- 9.96 11.80
ROE: -- 15.21 15.75

BRIEF-Bruker reports third quarter 2017 financial results

* Q3 revenue $435.6 million versus I/B/E/S view $414.6 million

Nov 02 2017

BRIEF-Bruker acquires Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper platform

* Bruker announces acquisition of Merlin to add selected antibiotic resistance and susceptibility testing to its Maldi Biotyper® microbial identification platform

Sep 26 2017

BRIEF-Bruker acquires XGLab with X-ray detection technologies, XRF instruments

* Bruker acquires company XGLab with unique X-ray detection technologies and XRF instruments for art & conservation markets

Aug 07 2017

BRIEF-Bruker Q2 non-gaap earnings per share $0.23

* Q2 revenue $414.9 million versus I/B/E/S view $385.5 million

Aug 03 2017

BRIEF-Bruker announces US FDA clearance of expanded 3rd claim for Maldi Biotyper

* Bruker announces US FDA clearance of expanded 3rd claim for Maldi Biotyper Source text for Eikon: Further company coverage:

Jul 31 2017

BRIEF-Bruker says Chris Ingen inteds to retire from co's board

* Bruker Corp - on June 22, 2017, Chris Van Ingen informed co of his intention to retire from company's board of directors, effective June 30

Jun 28 2017

Earnings vs. Estimates